avidinox
Small moleculeexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 11, 2013 (NCT02053324)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- avdinox
- avidinox
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03188328 | Phase 1 | Jun 1, 2017 | Leadiant Biosciences, Inc., University of Texas at Houston |
| NCT02053324 | Phase 1 | Nov 11, 2013 | Dell'Angelo Hospital, Mestre, Leadiant Biosciences, Inc., Medical University of Vienna, University of Basel, University of Roma La Sapienza |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Leadiant Biosciences, Inc. | For profit | 2 | 2 | 1 | 2013 |
| Dell'Angelo Hospital, Mestre | Academic/Hospital | 1 | 0 | 1 | 2013 |
| Medical University of Vienna | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Basel | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Roma La Sapienza | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2017 |
6 organizations
Page 1 / 1